Tectonic Therapeutic, Inc.

Tectonic Therapeutic, Inc.

Biotechnology • Healthcare • Watertown, MA, United States • TECX (NGM)

Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.

339 666 3320 490 Arsenal Way, Watertown, MA 02472, United States

Stock Performance (90 Days)

Data through Dec 26, 2025
Price updates on page refresh. Intraday quotes available during market hours (9:30 AM - 4:00 PM EST).

Layoff History

No layoff events recorded for this company.

Recent News

Tectonic Therapeutic (TECX): LifeSci Capital Reiterates Buy Rating - Yahoo Finance
Yahoo Finance • Dec 10
Analysts Are Bullish on Top Healthcare Stocks: Tectonic Therapeutic (TECX), Ultragenyx Pharmaceutical (RARE) - The Globe and Mail
The Globe and Mail • Jan 1
Why Tectonic Therapeutic Stock Soared 30% After-Hours Today - Stocktwits
Stocktwits • Oct 29
Tectonic Therapeutic stock soars after positive Phase 1b data for heart failure drug - Investing.com
Investing.com • Oct 29
Tectonic Therapeutic, Inc. (NASDAQ:TECX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
MarketBeat • Dec 25

Other Biotechnology Companies

View All →
CODEXIS, INC. logo Codexis, Inc.
1 layoff tracked
$144.5M market cap
VERTEX PHARMACEUTICALS INC / MA logo Vertex Pharmaceuticals Inc. / MA
$118.68B market cap
REGENERON PHARMACEUTICALS, INC. logo Regeneron Pharmaceuticals, Inc.
$82.72B market cap
ALNYLAM PHARMACEUTICALS, INC. logo Alnylam Pharmaceuticals, Inc.
$52.92B market cap
ARGENX SE logo Argenx SE
$52.62B market cap
INSMED Inc logo Insmed Inc.
$37.61B market cap

Frequently Asked Questions

Has Tectonic Therapeutic, Inc. had layoffs?
No layoff events have been recorded for Tectonic Therapeutic, Inc. in our database. This could mean the company has not conducted significant layoffs, or any layoffs have not been publicly reported.
How many employees does Tectonic Therapeutic, Inc. have?
Tectonic Therapeutic, Inc. has approximately 51 employees.
What industry is Tectonic Therapeutic, Inc. in?
Tectonic Therapeutic, Inc. operates in the Biotechnology industry, within the Healthcare sector.
Is Tectonic Therapeutic, Inc. a publicly traded company?
Yes, Tectonic Therapeutic, Inc. is publicly traded under the ticker symbol TECX on the NGM. The company has a market capitalization of approximately $0.39 billion.
Where is Tectonic Therapeutic, Inc. headquartered?
Tectonic Therapeutic, Inc. is headquartered in Watertown, MA, United States at 490 Arsenal Way, Watertown, MA 02472, United States.

Disclaimer

Data aggregated from public sources including WARN notices, SEC filings, press releases, and market data. While we strive for accuracy, information is provided "as-is" for informational purposes only. Always verify critical information with official company sources.

This information does not constitute investment, financial, legal, or career advice. See our Terms of Service, Privacy Policy, and About page for more information.

Found an error? Report it here.